> Detailanzeige

Matusche, Britta [VerfasserIn]; Litvin, Ludmila [VerfasserIn]; Schneider, Ruth [VerfasserIn]; Bellenberg, Barbara [VerfasserIn]; Mühlau, Mark [VerfasserIn]; Pongratz, Viola [VerfasserIn]; Berthele, Achim [VerfasserIn]; Groppa, Sergiu [VerfasserIn]; Muthuraman, Muthuraman [VerfasserIn]; Zipp, Frauke [VerfasserIn]; Paul, Friedemann [VerfasserIn]; Wiendl, Heinz [VerfasserIn]; Meuth, Sven G. [VerfasserIn]; Sämann, Philipp [VerfasserIn]; Weber, Frank [VerfasserIn]; Linker, Ralf A. [VerfasserIn]; Kümpfel, Tania [VerfasserIn]; Gold, Ralf [VerfasserIn]; Lukas, Carsten [VerfasserIn]

Early spinal cord pseudoatrophy in interferon‐beta‐treated multiple sclerosis

Literatur-
verwaltung

Zur
Merkliste

Lösche von
Merkliste

Per Whatsapp teilen

Schließen

Merkliste



Sie können Bookmarks mittels Listen verwalten, loggen Sie sich dafür bitte in Ihr SLUB Benutzerkonto ein.
  • Medientyp: E-Artikel
  • Titel: Early spinal cord pseudoatrophy in interferon‐beta‐treated multiple sclerosis
  • Beteiligte: Matusche, Britta [VerfasserIn]; Litvin, Ludmila [VerfasserIn]; Schneider, Ruth [VerfasserIn]; Bellenberg, Barbara [VerfasserIn]; Mühlau, Mark [VerfasserIn]; Pongratz, Viola [VerfasserIn]; Berthele, Achim [VerfasserIn]; Groppa, Sergiu [VerfasserIn]; Muthuraman, Muthuraman [VerfasserIn]; Zipp, Frauke [VerfasserIn]; Paul, Friedemann [VerfasserIn]; Wiendl, Heinz [VerfasserIn]; Meuth, Sven G. [VerfasserIn]; Sämann, Philipp [VerfasserIn]; Weber, Frank [VerfasserIn]; Linker, Ralf A. [VerfasserIn]; Kümpfel, Tania [VerfasserIn]; Gold, Ralf [VerfasserIn]; Lukas, Carsten [VerfasserIn]
  • Erschienen: Augsburg University Publication Server (OPUS), 2023
  • Sprache: Englisch
  • DOI: https://doi.org/10.1111/ene.15620
  • Entstehung:
  • Anmerkungen: Diese Datenquelle enthält auch Bestandsnachweise, die nicht zu einem Volltext führen.
  • Beschreibung: Background and purpose Brain pseudoatrophy has been shown to play a pivotal role in the interpretation of brain atrophy measures during the first year of disease-modifying therapy in multiple sclerosis. Whether pseudoatrophy also affects the spinal cord remains unclear. The aim of this study was to analyze the extent of pseudoatrophy in the upper spinal cord during the first 2 years after therapy initiation and compare this to the brain. Methods A total of 129 patients from a prospective longitudinal multicentric national cohort study for whom magnetic resonance imaging scans at baseline, 12 months, and 24 months were available were selected for brain and spinal cord volume quantification. Annual percentage brain volume and cord area change were calculated using SIENA (Structural Image Evaluation of Normalized Atrophy) and NeuroQLab, respectively. Linear mixed model analyses were performed to compare patients on interferon-beta therapy (n = 84) and untreated patients (n = 45). Results Patients treated with interferon-beta demonstrated accelerated annual percentage brain volume and cervical cord area change in the first year after treatment initiation, whereas atrophy rates stabilized to a similar and not significantly different level compared to untreated patients during the second year. Conclusions These results suggest that pseudoatrophy occurs not only in the brain, but also in the spinal cord during the first year of interferon-beta treatment.
  • Zugangsstatus: Freier Zugang